Thursday, 10. September 2026 · Next update: 18:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
📈 Economy · Next Month

Novo Nordisk A/S (NASDAQ: NVO) beats Q2 2026 adjusted EPS consensus of approx. $0.82 per ADS on August 5, 2026

Hit ✦ AI-generated prediction Published on 12. July 2026 · Predicted for 5. August 2026 · Based on: Historical Cycle
Probability
71%

Novo Nordisk reports Q2 2026 on August 5. The ADS EPS consensus stands at approximately $0.82 per TipRanks. GLP-1 demand for semaglutide (Ozempic/Wegovy) remains structurally strong; Novo benefits from global capacity expansion and growing reimbursements in Europe and the US. Competitive pressure from Eli Lilly (tirzepatide) is priced in. Novo has beaten EPS consensus in each of the last four quarters. Beat probability: 71%. Currency risk (DKK/USD, EUR/USD) could dampen USD ADS translation. No Polymarket market available.

Data basis for this prediction
  • TipRanks: NVO Q2-2026-EPS-Konsens ~0,82 USD ADS, Ergebnisdatum 05.08.2026
  • Trading Economics EUR/USD: 1,1416 am 12.07.2026 (Währungsrisiko DKK-Konversion beachten)
  • Novo Nordisk IR: Semaglutid-Kapazitätsausbaupläne 2025–2026; Ozempic/Wegovy globale Marktdaten

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit
Novo Nordisk übertraf am 5. August 2026 den bereinigten EPS-Konsens deutlich: Tatsächliches adjustiertes EPS: 0,9527 USD je ADS vs. Konsens 0,7815 USD – ein Beat von ca. +22 %. Auch der Umsatz (12,1 Mrd. USD vs. 10,94 Mrd. erwartet) übertraf die Erwartungen. Treiber waren weiterhin starke GLP-1-Nachfrage (Ozempic/Wegovy) sowie ein Rekordstart der oralen Wegovy-Pille in den USA. Quellen: Investing.com Earnings Call Transcript (https://www.investing.com/news/transcripts/earnings-call-transcript-novo-nordisk-beats-q2-2026-estimates-shares-rise-premarket-93CH-4837532), MarketBeat (https://www.marketbeat.com/earnings/reports/2026-8-5-novo-nordisk-as-stock/), Globe and Mail (https://www.theglobeandmail.com/investing/markets/stocks/NVO-N/pressreleases/3670985/novo-nordisk-lifts-2026-outlook-after-strong-q2-adjusted-results/).
Related Predictions
📈 Economy ✦ AI

DAX 40 (XETRA) closes above 26,000 points on 30 September 2026 (confirmed by XETRA closing price or Bloomberg by 30 September 2026)

The DAX closed at 25,562 points on September 9, 2026. A gain of +1.7% is required by month-end. Headwinds: ECB rate hike to 2.50% (September 10), 53% FOMC hike probability (September 16), persistently high oil prices (~$101/barrel Brent) weigh on energy-intensive DAX heavyweights. Tailwinds: strong SAP cloud growth expected, robust US demand, EUR/USD at 1.1644 benefits exporters. Implied 30-day volatility (VDAX): ~16%, corresponding to a σ range of roughly ±5.5% by month-end — the 26,000 level falls within the central distribution.

48%
Next Month · Predicted for 30. Sep 2026
📈 Economy ✦ AI

US Federal Reserve raises the Federal Funds target range by 25 basis points on 16 September 2026 (FOMC decision)

Polymarket shows a 53% probability for a 25 basis point hike as of September 10, 2026. US Core CPI August 2026 (release September 11) is expected by market consensus to be above 3.0% YoY. The ECB raised its deposit rate by 25 bps to 2.50% on September 10, 2026 – an inflation-fighting signal that provides cover for the Fed. Against a hike: a mild slowdown in US industrial output. CME FedWatch also shows ~53% probability for a hike.

53%
Next Week · Predicted for 16. Sep 2026
📈 Economy ✦ AI

Bitcoin (BTC/USD spot) closes above $100,000 per unit on December 31, 2026 (confirmed by Bloomberg or CoinGecko by December 31, 2026)

Bitcoin at $78,136 (September 9, 2026). Kalshi markets assign ~83% probability of BTC touching $100,000 at any point in 2026. Polymarket gives BTC 68% odds to close above $90,000 by year-end. A year-end close above $100,000 (not just a touch) is more demanding: median year-end contract estimates imply ~$81,000. Arguments for >$100k close: historical Q4 seasonality (+49% in Q4 2024, +56% in Q4 2023), ETF inflows, institutional demand. Headwinds: active Fed hiking cycle (~3.75% current funds rate), 10yr yield at 4.86%.

42%
Next Year · Predicted for 31. Dec 2026